ATPase inhibitory factor 1 is a potential prognostic marker for the migration and invasion of glioma

Oncology Letters

Volumn 10, Issue 4, 2015, Pages 2075-2080

  Wu, Jianheng ^a   Shan, Qiao ^a   Li, Peidong ^a   Wu, Yuehui ^a   Xie, Jingwei ^a   Wang, Xinjun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adenosine triphosphatase inhibitory factor 1; Glioma; Invasion; Migration; Prognosis

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITORY FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDES AND PROTEINS; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN SNAI1;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE; PROGNOSTIC ASSESSMENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR INVASION; WESTERN BLOTTING;

EID: 84940037225     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3548     Document Type: Article

References (22)

1. Li PD, Wang XJ, Shan Q, Wu YH and Wang Z: Evaluation of TAZ expression and its effect on tumor invasion and metastasis in human glioma. Asian Pac J Trop Med 7: 757-760, 2014.
2. Brat DJ, Scheithauer BW, Fuller GN and Tihan T: Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system: Angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 17: 319-324, 2007.
3. Hagemann C, Fuchs S, Monoranu CM, Herrmann P, Smith J, Hohmann T, Grabiec U, Kessler AF, Dehghani F, Löhr M, et al: Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Neuro Oncol 15: 1696-1709, 2013.
4. Cuezva JM, Ortega AD, Willers I, Sánchez-Cenizo L, Aldea M and Sánchez-Aragó M: The tumor suppressor function of mitochondria: Translation into the clinics. Biochim Biophys Acta 1792: 1145-1158, 2009.
5. Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell 144: 646-674, 2011.
6. Kroemer G and Pouyssegur J: Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13: 472-482, 2008.
7. Faccenda D, Tan CH, Seraphim A, Duchen MR and Campanella M: IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling. Cell Death Differ 20: 686-697, 2013.
8. Sánchez-Cenizo L, Formentini L, Aldea M, Ortega AD, García-Huerta P, Sánchez-Aragó M and Cuezva JM: Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem 285: 25308-25313, 2010.
9. Formentini L, Sánchez-Aragó M, Sánchez-Cenizo L and Cuezva JM: The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Mol Cell 45: 731-742, 2012.
10. Sánchez-Aragó M, Formentini L, Martinez-Reyes I, García-Bermudez J, Santacatterina F, Sánchez-Cenizo L, Willers IM, Aldea M, Nájera L, Juarránz A, et al: Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis 2: e46, 2013.
11. Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, Wang J, Lu Z, Song X, Pei T, et al: Reciprocal activation between ATPase inhibitory factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology 60: 1659-1673, 2014.
12. World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310: 2191-2194, 2013.
13. Tu K, Li C, Zheng X, Yang W, Yao Y and Liu Q: Prognostic significance of miR-218 in human hepatocellular carcinoma and its role in cell growth. Oncol Rep 32: 1571-1577, 2014.
14. Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y and Liu Q: Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol Cancer 13: 110, 2014.
15. Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu K and Liu Q: SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int J Mol Sci 15: 7124-7138, 2014.
16. Calzia D, Candiani S, Garbarino G, Caicci F, Ravera S, Bruschi M, Manni L, Morelli A, Traverso CE, Candiano G, et al: Are rod outer segment ATP-ase and ATP-synthase activity expression of the same protein? Cell Mol Neurobiol 33: 637-649, 2013.
17. Zarco-Zavala M, Morales-Ríos E, Mendoza-Hernández G, Ramírez-Silva L, Pérez-Hernández G and García-Trejo JJ: The ζ subunit of the F1FO-ATP synthase of α-proteobacteria controls rotation of the nanomotor with a different structure. FASEB J 28: 2146-2157, 2014.
18. Katoh M and Katoh M: Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT and NF-kappaB. Int J Oncol 34: 1737-1742, 2009.
19. Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, et al: The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 25: 2594-2609, 2011.
20. Katsuno Y, Lamouille S and Derynck R: TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25: 76-84, 2013.
21. Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Itoh T, Ohba Y, Nishihara H, Shirato H, Tsuda M and Tanaka S: Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro Oncol 16: 671-685, 2014.
22. Yan YR, Xie Q, Li F, Zhang Y, Ma JW, Xie SM, Li HY and Zhong XY: Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells. Neuropathology 34: 128-134, 2014.